Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization (Q48497489)

12 February 2018

title

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization (English)

1 reference

12 February 2018

0 references

0 references

1 reference

Sebastiaan Engelborghs

7

Sebastiaan Engelborghs

1 reference

12 February 2018

Julius Popp

Julius Popp

13

0 references

Barbara Mroczko

Barbara Mroczko

11

0 references

José Luis Molinuevo

José Luis Molinuevo

10

0 references

Johannes Kornhuber

19

Johannes Kornhuber

1 reference

12 February 2018

9

Henrik Zetterberg

1 reference

12 February 2018

12

Kaj Blennow

1 reference

12 February 2018

8

Charlotte E Teunissen

1 reference

12 February 2018

14

Lucilla Parnetti

1 reference

12 February 2018

Sebastian Brandner

Sebastian Brandner

6

1 reference

ORCID Public Data File 2021

Max Holzer

Max Holzer

4

0 references

Piotr Lewczuk

1

Piotr Lewczuk

1 reference

12 February 2018

author name string

Natalia Lelental

2

1 reference

12 February 2018

Ingolf Lachmann

3

1 reference

12 February 2018

Katharina Flach

5

1 reference

12 February 2018

Davide Chiasserini

15

1 reference

12 February 2018

Armand Perret-Liaudet

16

1 reference

12 February 2018

Philipp Spitzer

17

1 reference

12 February 2018

Juan Manuel Maler

18

1 reference

12 February 2018

publication date

20 September 2016

1 reference

12 February 2018

Journal of Alzheimer's Disease

published in

1 reference

12 February 2018

volume

55

1 reference

12 February 2018

issue

1

1 reference

12 February 2018

page(s)

159-170

1 reference

12 February 2018

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau immunotherapy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau oligomers impair artificial membrane integrity and cellular viability

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Microtubule-associated protein tau in development, degeneration and protection of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau protein kinases: involvement in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Biochemistry and cell biology of tau protein in neurofibrillary degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-160448

21 January 2018

Identifiers

DOI

10.3233/JAD-160448

0 references

1 reference

12 February 2018